TY - JOUR
T1 - Dermatologic lupus
T2 - Hopkins Lupus Cohort
AU - Petri, M.
PY - 1998
Y1 - 1998
N2 - Dermatologic manifestations are among the most common signs of systemic lupus erythematosus (SLE). The Hopkins Lupus Cohort study is a prospective study in which patients with SLE are seen on a quarterly basis for measurement of disease activity, laboratory tests, and assessment of morbidity and quality of life. This cohort has allowed unique insights into the epidemiologic factors of SLE, the presentation of dermatologic lupus, and morbidity, all of which are presented in this report. In addition, the dermatologic signs of antiphospholipid antibody syndrome (APS) are reviewed. Approaches to treatment of dermatologic lupus and APS are discussed.
AB - Dermatologic manifestations are among the most common signs of systemic lupus erythematosus (SLE). The Hopkins Lupus Cohort study is a prospective study in which patients with SLE are seen on a quarterly basis for measurement of disease activity, laboratory tests, and assessment of morbidity and quality of life. This cohort has allowed unique insights into the epidemiologic factors of SLE, the presentation of dermatologic lupus, and morbidity, all of which are presented in this report. In addition, the dermatologic signs of antiphospholipid antibody syndrome (APS) are reviewed. Approaches to treatment of dermatologic lupus and APS are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0031720416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031720416&partnerID=8YFLogxK
U2 - 10.1016/S1085-5629(98)80017-5
DO - 10.1016/S1085-5629(98)80017-5
M3 - Review article
C2 - 9759680
AN - SCOPUS:0031720416
SN - 1085-5629
VL - 17
SP - 219
EP - 227
JO - Seminars in cutaneous medicine and surgery
JF - Seminars in cutaneous medicine and surgery
IS - 3
ER -